EXHIBIT 99.1
------------
IVOICE
750 HIGHWAY 34
MATAWAN NJ 07747
PRESS RELEASE
FOR IMMEDIATE RELEASE
- ---------------------
IVOICE, INC., ANNOUNCES RECORD DATE FOR
SPIN-OFF OF THOMAS PHARMACEUTICALS LTD.
TO SHAREHOLDERS
FIFTH SPIN-OFF AND FIFTH STOCK DIVIDEND
---------------------------------------
TO THE SHAREHOLDERS
-------------------
MATAWAN, NJ, OCTOBER 9, 2007 -- iVoice, Inc. (OTC Bulletin Board: IVOI),
announced today the record date of October 15, 2007 for the pending spin-off in
the form of a special dividend of its wholly owned subsidiary, THOMAS
PHARMACEUTICALS LTD. ("THOMAS PHARMACEUTICALS").
Each iVoice shareholder as of the record date as of October 15 2007 will receive
shares of THOMAS PHARMACEUTICALS subject to: (i) the record date having passed,
(ii) the Securities and Exchange Commission reviewing and approving the final
amendment to the Thomas Pharmaceuticals' Form SB-2/A and (iii) declaration of
effectiveness of this registration statement by the Securities and Exchange
Commission. In order to receive shares in Thomas Pharmaceuticals, you must own
shares of iVoice, Inc. on the record date of October 15, 2007. It is anticipated
that the distribution in the form of a special dividend of Thomas
Pharmaceuticals shares will occur sometime in November 2007. Following the
distribution, Thomas Pharmaceuticals plans to have its shares traded on the NASD
OTC Bulletin Board.
ABOUT IVOICE, INC:
iVoice has determined that the best way to create shareholder value, separate
and apart from the operating performance of iVoice, is to implement new business
opportunities by distributing shares of spin-offs to the Company's shareholders.
The common stock distributions are part of a broader strategy relating to the
transition of iVoice into a company focused on the development and licensing of
proprietary technologies. We also continue to search for potential merger
candidates with or without compatible technology and products, which management
feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain forward-looking
statements about our current and expected performance trends, growth plans,
business goals and other matters. These statements may be contained in our
filings with the Securities and Exchange Commission, in our press releases, in
other written communications, and in oral statements made by or with the
approval of one of our authorized officers. Information set forth in this press
release contains various "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the
"Act") provides certain "safe harbor" provisions for forward-looking statements.
The reader is cautioned that such forward-looking statements are based on
information available at the time and/or management's good faith belief with
respect to future events, and are subject to risks and uncertainties that could
cause actual performance or results to differ materially from those expressed in
the statements. Forward-looking statements speak only as of the date the
statement was made. We assume no obligation to update forward-looking
information to reflect actual results, changes in assumptions or changes in
other factors affecting forward-looking information. Forward-looking statements
are typically identified by the use of terms such as "anticipate," "believe,"
"could," "estimate," "expect," "intend," "may," "might," "plan," "predict,"
"project," "should," "will," and similar words, although some forward-looking
statements are expressed differently. Although we believe that the expectations
reflected in such forward-looking statements are reasonable, we can give no
assurance that such expectations will prove to be correct.
For more information on iVoice, please visit http://www.ivoice.com
Contact:
Dolores Serafin
732-441-7700